Maryland Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Maryland Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$586K	Buy	1,155 +485	+72%	+$271K	0.05%	136
2022 Q2	$364K	Sell	670 -50	-7%	-$27.5K	0.03%	172
2022 Q1	$425K	Sell	720 -83	-10%	-$47.7K	0.03%	175
2021 Q4	$536K	Buy	803 +47	+6%	+$29.3K	0.03%	163
2021 Q3	$432K	Sell	756 -25	-3%	-$13.7K	0.03%	176
2021 Q2	$394K	Buy	781 +102	+15%	+$48.1K	0.02%	184
2021 Q1	$310K	Sell	679 -47	-6%	-$22.4K	0.02%	197
2020 Q4	$338K	Buy	726 +225	+45%	+$105K	0.02%	180
2020 Q3	$221K	Buy	+501	New	+$207K	0.02%	192

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maryland Capital Management's TMO Position: Q3 2022 in Review

Maryland Capital Management increased its Thermo Fisher Scientific (TMO) stake by 72% in Q3 2022, buying an estimated $271K and bringing the position to 1,155 shares worth $586K. The position accounts for 0.05% of the portfolio, ranked #136.

Maryland Capital Management first reported a position in TMO in Q3 2020 and has held it in 9 quarters since. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

Maryland Capital Management held 1,155 shares of Thermo Fisher Scientific worth $586K as of Q3 2022.
Maryland Capital Management bought 485 Thermo Fisher Scientific shares in Q3 2022, an estimated $271K.
Thermo Fisher Scientific made up 0.05% of Maryland Capital Management's portfolio in Q3 2022, its #136 holding.
Maryland Capital Management first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 9 quarters since.
2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on Maryland Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.